Moderator note: Great discussion, everyone. Just a reminder to keep things civil and evidence-based.
Thread quality is excellent — keep it up. 👍
Clinical perspective on Type 1.5 diabetes (LADA) and GLP-1 what:
I have managed roughly 300 patients on GLP-1 therapy and this topic comes up frequently. What the data shows — and what I see in practice — is that proper titration prevents most adverse events.
For this specific question, I would recommend: reviewing the relevant clinical guidelines.
Admin said:Just a reminder to keep things civil and evidence-based
I respect Admin perspective but I think this oversimplifies things a bit. Re: Type 1.5 diabetes (LADA) and — the effect size varies considerably by population.
I am not saying Admin wrong entirely — just that the picture is more nuanced than a blanket statement. The STEP data specifically shows dose-dependent variation.
Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.
Shop Reference StandardsReading this thread on Type 1.5 diabetes (LADA) hits close to home. Dad of 2 checking in — I started at 269 lbs and felt like I would tried everything.
15 months on tirz and I am a different person. Not just the 44 lbs lost — my energy, my mood, my relationship with food. All transformed.
If you are on the fence about Type 1.5 diabetes — take the leap. It was the best health decision I have ever made. ❤️
Bookmarked 📌 The Type 1.5 diabetes info in this thread is essential. Coming back to this for sure.